Applying for fellowship? This program will help you find the right program, make your ERAS CV stand out from the crowd, ace the interview, and what to do if you don't match.

Alcohol-associated liver disease (ALD) has surged as an indication for transplant, increasing over 5-fold in the past 20 years, and is now the #1 indication for transplant in the US. Early (i.e. without mandated period of abstinence) transplant has partly

This session will bring together leading experts in the field of Alcohol-associated Liver Disease (ALD) to discuss the challenges and strategies for the future of this field. ALD remains a significant public health concern, with a rising prevalence and a

The sexual and gender minorities (SGM) people faced not only health but also psychosocial, economic, and legal disparities in accessing and receiving healthcare in general. Although specific data on liver transplants is limited, we believe such disparity

This Community Conversation updates members on the range of current online career development offerings, shares the AASLD vision for the future of online learning and provides an open forum for discussion to provide feedback on the future of AASLDs online

This program will feature advice to help investigators build a strong foundation to support the critical transitional years between completing training and establishing themselves as an independent investigator.

National Institute of Alcohol Abuse and Alcoholism Director Dr. George Koob will present opening remarks on NIAAA’s liver-related work while Dr. Joe Wang will be in person to present on research opportunities and answer audience questions.

Through applied clinical informatics, electronic health record (EHR) embedded interventions represent an opportunity for enhancing and standardizing care delivery to ensure equitable outcomes. Through utilization of scalable solutions, the field of clinic

This session will review the latest evidence-based recommendations on the safety and This session will review the latest evidence-based recommendations on the safety and efficacy of COVID-19 vaccines in patients with chronic liver disease and liver transp

This session will be a review of common conundrums that are faced by hepatologists. We will hear from experts in the field to hear their management of choice for difficult circumstances.